ArticleeLife2023

Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford progeria syndrome.

Sae-Il Murtada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.